XNAS
AAME
Market cap24mUSD
Oct 08, Last price
1.21USD
1D
-1.63%
1Q
-28.40%
Jan 2017
-70.49%
Name
Atlantic American Corp
Chart & performance
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
Atlantic American Corporation (AAME) is an insurance holding company that, through its subsidiaries, delivers a diverse range of life, health, and property & casualty insurance offerings throughout the United States. Its operations are segmented into American Southern and Bankers Fidelity. Within its property and casualty division, AAME underwrites commercial auto coverage tailored for state and local government agencies, as well as various motor pool and fleet operators. This division also furnishes inland marine and general liability insurance. Additionally, it offers surety bonds, including those for subdivision development, school bus service contracts, and guarantees of performance and payment. Furthermore, the company's life and health insurance portfolio encompasses both individual and group whole life policies, alongside Medicare supplement plans. It also extends a suite of additional accident and health coverages. These include specific individual and group policies providing benefits for diagnosed cancer and other critical illnesses, as well as policies for short-term nursing facility care, accident expenses, hospital indemnity, and disability protection. Distribution of its diverse product lines is managed through a network of independent agents and brokers. Established in 1937, Atlantic American Corporation maintains its corporate headquarters in Atlanta, Georgia.
Key people
Chairman of the Board, President, Chief Executive Officer · since 2009
J. Ross Franklin
Chief Financial Officer, Vice President, Corporate Secretary · since 2017
Director · since 2012
Scot Thompson
Director · since 1996
Mark Preisinger
Independent Director · since 2017
Joseph Scheerer
Independent Director · since 2017
D. Keehln Wheeler
Independent Director · since 2017
Valuation
Title USD in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|---|
| 2024‑12 | 2023‑12 | 2022‑12 | 2021‑12 | 2020‑12 | 2019‑12 | 2018‑12 | 2017‑12 | 2016‑12 | |
| Income | |||||||||
Revenues | |||||||||
Cost of revenue | |||||||||
Unusual Expense (Income) | |||||||||
NOPBT | |||||||||
NOPBT Margin | |||||||||
Operating Taxes | |||||||||
Tax Rate | |||||||||
NOPAT | |||||||||
Net income | |||||||||
Dividends | |||||||||
Dividend yield | |||||||||
Proceeds from repurchase of equity | |||||||||
BB yield | |||||||||
| Debt | |||||||||
Debt current | |||||||||
Long-term debt | |||||||||
Deferred revenue | |||||||||
Other long-term liabilities | |||||||||
Net debt | |||||||||
| Cash flow | |||||||||
Cash from operating activities | |||||||||
CAPEX | |||||||||
Cash from investing activities | |||||||||
Cash from financing activities | |||||||||
FCF | |||||||||
| Balance | |||||||||
Cash | |||||||||
Long term investments | |||||||||
Excess cash | |||||||||
Stockholders' equity | |||||||||
Invested Capital | |||||||||
ROIC | |||||||||
ROCE | |||||||||
| EV | |||||||||
Common stock shares outstanding | |||||||||
Price | |||||||||
Market cap | |||||||||
EV | |||||||||
EBITDA | |||||||||
EV/EBITDA | |||||||||
Interest | |||||||||
Interest/NOPBT | |||||||||